SPIRIT-H2H results confirm superiority of ixekizumab over adalimumab for PsANovember 21, 2019Psoriatic ArthritisPsoriasis
FDA announces approval of fifth adalimumab biosimilar, AbriladaNovember 18, 2019Psoriatic ArthritisPsoriasis
Expert shares tips for TNF-alpha inhibitor use in special populationsNovember 12, 2019PsoriasisPsoriatic Arthritis
Narrowband UVB phototherapy an effective treatment for psoriasisNovember 12, 2019PsoriasisPsoriatic Arthritis
Guselkumab improves psoriatic arthritis regardless of prior TNFi useNovember 11, 2019Psoriatic ArthritisPsoriasis
AAD-NPF Pediatric psoriasis guideline advises on physical and mental careNovember 9, 2019PediatricsPsoriatic ArthritisPsoriasis
Observational secukinumab data reflect clinical trial results in patients with moderate to severe psoriasisNovember 9, 2019PsoriasisPsoriatic Arthritis
New psoriatic patients may have lower serious infection risk with IL-12/23 inhibitionNovember 6, 2019Psoriatic ArthritisPsoriasis
Severe psoriasis associated with increased cancer risk, mortalityNovember 1, 2019PsoriasisPsoriatic Arthritis
Psoriasis risk rises with TNF inhibitor use in children with inflammatory disordersOctober 30, 2019PediatricsPsoriasis
